Developer docs
API playgroundTry for free, no card

Search company profiles

CardioCell

Full company profile

uuid000b5ay

Namestring
CardioCell
Company typeenum
Private
Founded yearint
2013
Descriptiontext

CardioCell is a privately-held, clinical-stage biotechnology company headquartered in San Diego, California, founded in 2013. According to firmographic data, the company is focused on developing "off-the-shelf" stem cell-based therapeutic products and is currently running clinical trials for these candidates. The company operates with a small team of 1-10 employees, consistent with an early-stage biotech in the pre-commercial phase.

The company's core offering centers on stem cell-derived therapeutic products intended to be deployable as ready-to-use, standardized treatments rather than patient-specific autologous therapies — a positioning that, if validated clinically, would address the scalability limitations common in cell therapy. CardioCell's business model is not yet commercial; as a clinical-stage developer, the company is pre-revenue and presumably funded through equity capital, grants, or strategic partnerships, none of which are disclosed in the available input.

The bulk of the aggregated input describes an unrelated Indonesian online gambling platform branded "Slot777" and operating from the domain scarletpawsanimalwelfare.org. This data does not pertain to CardioCell and is not used to characterize the biotech's products, customers, or revenue mechanics. CardioCell has no disclosed customers, partnerships, funding rounds, leadership team, regulatory actions, or M&A activity in the input — a material data gap that constrains any forward-looking assessment.

Short descriptiontext

CardioCell is a privately-held, clinical-stage biotechnology company founded in 2013 and based in San Diego, California, developing "off-the-shelf" stem cell-based therapeutic products currently in clinical trials, with a small team of 1-10 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
online slot gambling, live casino games, sports betting platform, togel lottery online, multi-provider casino aggregation
Industry3 codes
1Real-Money Online Casino Operators (RNG Slots & Table Games)
CodeMPAEABAAPrimaryYes
2iGaming Platform Providers (Turnkey/Casino & Sportsbook Platforms)
CodeMPAEAKAAPrimaryNo
3Payments Orchestration, Wallets & Alternative Payments Enablement
CodeMPAEAKAHPrimaryNo
Product category
Online gambling platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1House Edge from Slot Games
TypeTransaction Fee
Description

Platform takes a percentage cut from all slot machine bets placed by players, generating revenue through the mathematical house advantage built into slot game RTPs

scarletpawsanimalwelfare.org
2Casino and Live Dealer Games
TypeTransaction Fee
Description

Revenue from live casino games including baccarat, blackjack, and roulette with house edge applied to wagers

scarletpawsanimalwelfare.org
3Sports Betting
TypeTransaction Fee
Description

Sportsbook gaming platform with odds-based house margin on sports wagers including football, basketball, and e-sports

scarletpawsanimalwelfare.org
4Togel/Lottery
TypeTransaction Fee
Description

Togel lottery platform offering prize payouts funded by player wagers with platform retaining a portion

scarletpawsanimalwelfare.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Marketing or Sales, Personnel, Others
Pricing details1 tier
1Minimum deposit slot play - 1000 IDR
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Players can start playing slot games with minimum deposit of 1000 IDR (roughly $0.06 USD). Platform claims to offer 'maxwin' jackpot opportunities with small deposits.

scarletpawsanimalwelfare.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CardioCell operates an Indonesia-targeted online gambling platform (DBA: Slot777) that aggregates more than 30 third-party game providers into a single self-serve web account. Offerings span video slots, live casino, sports betting, togel lottery, crash games, arcade, poker, e-sports, and sabung ayam (cockfighting). The platform monetizes via house edge / transaction fees on wagers and differentiates on a 1000 IDR (~USD 0.06) minimum deposit with full Indonesian e-wallet and QRIS payment integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Average deposit processing time of 1 minute
+1 more record
Product and service10 records
1Slot Games (Video Slots)
CategoryOnline slot gambling
Description

Aggregated online slot-machine gaming product for individual Indonesian players. Users register, deposit from 1000 IDR via DANA/OVO/GoPay/QRIS/bank transfer, and wager on third-party video-slot titles across 30+ providers under a single account.

2Live Casino
CategoryLive dealer casino
Description

Live-dealer casino product for individual Indonesian players wanting real-time table games (baccarat, blackjack, roulette, etc.) with house-edge wagering.

3Sports Betting (Olahraga)
CategoryOnline sports betting
Description

Online sportsbook for Indonesian consumers placing wagers on football, basketball, e-sports and other events at odds-based house-margin pricing.

4Togel (Lottery)
CategoryOnline lottery / togel
Description

Online togel (Indonesian numbers lottery) product for individual consumers wagering on lottery draws with prize payouts from the player pool.

5Crash Game
CategoryCrash / instant-win gambling
Description

Crash-style gambling product offering multiplier-based cash-out games for individual players seeking fast-round wagering.

6Arcade Games
CategoryArcade gambling
Description

Casual-format arcade gambling games for individual players seeking non-traditional wager formats alongside slots and casino.

7Poker
CategoryOnline poker
Description

Online poker product for individual Indonesian players wagering on card-based poker games within the platform.

8E-Sports Betting
CategoryE-sports betting
Description

E-sports betting product for individual consumers wagering on competitive video-gaming events through the platform.

9Sabung Ayam (Cockfighting)
CategoryCockfighting / sabung ayam betting
Description

Sabung ayam (cockfighting) wagering product for individual consumers in markets where the category is offered on the platform.

10Race / Virtual Racing
CategoryVirtual / live race betting
Description

Virtual / live race wagering product for individual players betting on horse or other racing events within the platform.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or Integration
Description

Major game provider supplying slot games to the platform including popular titles like Gates of Olympus 1000, Starlight Princess, and various other video slots. Platform prominently features Pragmatic Play games as primary content.

Strategic tierCoreTypeTechnology or Integration
Description

Game provider supplying mobile-optimized slot games including Mahjong Ways and Lucky Neko. Featured prominently in platform's game catalog.

Strategic tierCoreTypeTechnology or Integration
Description

Primary e-wallet payment method for deposits and withdrawals. Key payment integration for Indonesian market accessibility.

Strategic tierCoreTypeTechnology or Integration
Description

Standardized QR payment system marked as 'Recommended' for deposits. Enables broad payment interoperability.

Peers10 records
TypeBroad incumbent
Description

Long-established Asian online gambling operator offering sportsbook, casino, and slots across multiple Southeast Asian markets. Comparable because it serves the same regional player base with a similarly broad gambling vertical mix, though at a much larger scale and with licensed, regulated market access.

TypeBroad incumbent
Description

Asian-focused online sportsbook and casino operator with deep penetration in Indonesia and surrounding markets. Comparable because it monetizes the same Indonesian casual bettor persona through sports, casino, and slot verticals, often through local agents.

TypeBroad incumbent
Description

Global online sportsbook and casino operator with significant emerging-market presence including Indonesia. Comparable due to multi-vertical offering (sports, casino, slots, live dealer) and similar emphasis on local payment methods and low minimum stakes.

TypeDirect peer
Description

Indonesia-headquartered online poker network that also distributes adjacent casino and slot content to Indonesian-facing agents. Comparable because it shares the same Indonesian player base, multi-provider aggregation model, and reliance on local payment rails.

TypeEmerging player
Description

Major iGaming content provider whose slot and live-casino titles (e.g. Gates of Olympus 1000) are the anchor content on Slot777. Comparable as both an upstream supplier and a brand that increasingly operates its own branded aggregation and operator services into Indonesia-adjacent markets.

TypeEmerging player
Description

Mobile-first slot game provider (Mahjong Ways, Lucky Neko) heavily distributed on Indonesian gambling platforms. Comparable because it competes for the same Indonesian casual-slot player attention and increasingly bundles distribution/operator services.

TypeEmerging player
Description

Slot and table-game provider distributed across Asian-facing aggregators including Slot777. Comparable because it both supplies and competes for shelf-space inside Indonesian multi-provider gambling platforms.

TypeBroad incumbent
Description

Large European-listed iGaming platform and content provider supplying live casino, slots, and poker to Slot777. Comparable as both a technology incumbent whose content drives the platform's live-casino vertical and a potential competing operator in regulated jurisdictions.

TypeBroad incumbent
Description

Global leader in live-dealer casino content, dominant across Asian-facing operators. Comparable because it provides the live-casino experience layer that Slot777 resells and is itself moving into slots via acquisitions (NetEnt, Red Tiger), blurring the operator/provider line.

TypeBroad incumbent
Description

Global online gambling incumbent operating sportsbook, casino, and poker across dozens of regulated markets. Comparable as a benchmark for the multi-vertical online gambling business model Slot777 is pursuing, though with a regulated-market profile and vastly larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CardioCell

Online gambling platformstemcardiocell.com

CardioCell is a privately-held, clinical-stage biotechnology company founded in 2013 and based in San Diego, California, developing "off-the-shelf" stem cell-based therapeutic products currently in clinical trials, with a small team of 1-10 employees.

What CardioCell does

CardioCell is a privately-held, clinical-stage biotechnology company headquartered in San Diego, California, founded in 2013. According to firmographic data, the company is focused on developing "off-the-shelf" stem cell-based therapeutic products and is currently running clinical trials for these candidates. The company operates with a small team of 1-10 employees, consistent with an early-stage biotech in the pre-commercial phase.

The company's core offering centers on stem cell-derived therapeutic products intended to be deployable as ready-to-use, standardized treatments rather than patient-specific autologous therapies — a positioning that, if validated clinically, would address the scalability limitations common in cell therapy. CardioCell's business model is not yet commercial; as a clinical-stage developer, the company is pre-revenue and presumably funded through equity capital, grants, or strategic partnerships, none of which are disclosed in the available input.

The bulk of the aggregated input describes an unrelated Indonesian online gambling platform branded "Slot777" and operating from the domain scarletpawsanimalwelfare.org. This data does not pertain to CardioCell and is not used to characterize the biotech's products, customers, or revenue mechanics. CardioCell has no disclosed customers, partnerships, funding rounds, leadership team, regulatory actions, or M&A activity in the input — a material data gap that constrains any forward-looking assessment.

CardioCell firmographics

Firmographics
Name
CardioCell
Website
https://stemcardiocell.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
CardioCell is a privately-held, clinical-stage biotechnology company founded in 2013 and based in San Diego, California, developing "off-the-shelf" stem cell-based therapeutic products currently in clinical trials, with a small team of 1-10 employees.
Ownership category
akta.pro rank

CardioCell industry classification

Industry
Product category
Online gambling platform
akta.pro primary industry
Real-Money Online Casino Operators (RNG Slots & Table Games) (MPAEABAA)
akta.pro secondary industries
iGaming Platform Providers (Turnkey/Casino & Sportsbook Platforms) (MPAEAKAA), Payments Orchestration, Wallets & Alternative Payments Enablement (MPAEAKAH)

Keywords

  • Online slot gambling
  • Live casino games
  • Sports betting platform
  • Togel lottery online
  • Multi-provider casino aggregation

Where CardioCell is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Markets served

CardioCell business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Operations, Marketing or Sales, Personnel, Others

Revenue model

  1. House Edge from Slot Games: Platform takes a percentage cut from all slot machine bets placed by players, generating revenue through the mathematical house advantage built into slot game RTPs
  2. Casino and Live Dealer Games: Revenue from live casino games including baccarat, blackjack, and roulette with house edge applied to wagers
  3. Sports Betting: Sportsbook gaming platform with odds-based house margin on sports wagers including football, basketball, and e-sports
  4. Togel/Lottery: Togel lottery platform offering prize payouts funded by player wagers with platform retaining a portion

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMinimum deposit slot play - 1000 IDR

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

CardioCell product offering

Product offering

Core offering

CardioCell operates an Indonesia-targeted online gambling platform (DBA: Slot777) that aggregates more than 30 third-party game providers into a single self-serve web account. Offerings span video slots, live casino, sports betting, togel lottery, crash games, arcade, poker, e-sports, and sabung ayam (cockfighting). The platform monetizes via house edge / transaction fees on wagers and differentiates on a 1000 IDR (~USD 0.06) minimum deposit with full Indonesian e-wallet and QRIS payment integration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Slot Games (Video Slots) Aggregated online slot-machine gaming product for individual Indonesian players. Users register, deposit from 1000 IDR via DANA/OVO/GoPay/QRIS/bank transfer, and wager on third-party video-slot titles across 30+ providers under a single account.
  • Live Casino Live-dealer casino product for individual Indonesian players wanting real-time table games (baccarat, blackjack, roulette, etc.) with house-edge wagering.
  • Sports Betting (Olahraga) Online sportsbook for Indonesian consumers placing wagers on football, basketball, e-sports and other events at odds-based house-margin pricing.
  • Togel (Lottery) Online togel (Indonesian numbers lottery) product for individual consumers wagering on lottery draws with prize payouts from the player pool.
  • Crash Game Crash-style gambling product offering multiplier-based cash-out games for individual players seeking fast-round wagering.
  • Arcade Games Casual-format arcade gambling games for individual players seeking non-traditional wager formats alongside slots and casino.
  • Poker Online poker product for individual Indonesian players wagering on card-based poker games within the platform.
  • E-Sports Betting E-sports betting product for individual consumers wagering on competitive video-gaming events through the platform.
  • Sabung Ayam (Cockfighting) Sabung ayam (cockfighting) wagering product for individual consumers in markets where the category is offered on the platform.
  • Race / Virtual Racing Virtual / live race wagering product for individual players betting on horse or other racing events within the platform.

Quantifiable outcome

  • Average deposit processing time of 1 minute
  • +1 more outcomes

Companies that use CardioCell

Customer profile

Named customers6 records

Segments1 record

Ideal customer profiles1 record

CardioCell technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CardioCell partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Pragmatic PlaycoreTechnology or IntegrationMajor game provider supplying slot games to the platform including popular titles like Gates of Olympus 1000, Starlight Princess, and various other video slots. Platform prominently features Pragmatic Play games as primary content.
  • PG SoftcoreTechnology or IntegrationGame provider supplying mobile-optimized slot games including Mahjong Ways and Lucky Neko. Featured prominently in platform's game catalog.
  • DANAcoreTechnology or IntegrationPrimary e-wallet payment method for deposits and withdrawals. Key payment integration for Indonesian market accessibility.
  • QRIScoreTechnology or IntegrationStandardized QR payment system marked as 'Recommended' for deposits. Enables broad payment interoperability.

Scale indicators2 records

CardioCell competitors and assessment

Company assessment

Broad incumbents

  • Sbobet: Long-established Asian online gambling operator offering sportsbook, casino, and slots across multiple Southeast Asian markets. Comparable because it serves the same regional player base with a similarly broad gambling vertical mix, though at a much larger scale and with licensed, regulated market access.
  • Maxbet: Asian-focused online sportsbook and casino operator with deep penetration in Indonesia and surrounding markets. Comparable because it monetizes the same Indonesian casual bettor persona through sports, casino, and slot verticals, often through local agents.
  • 1xBet: Global online sportsbook and casino operator with significant emerging-market presence including Indonesia. Comparable due to multi-vertical offering (sports, casino, slots, live dealer) and similar emphasis on local payment methods and low minimum stakes.
  • Playtech: Large European-listed iGaming platform and content provider supplying live casino, slots, and poker to Slot777. Comparable as both a technology incumbent whose content drives the platform's live-casino vertical and a potential competing operator in regulated jurisdictions.
  • Evolution Gaming: Global leader in live-dealer casino content, dominant across Asian-facing operators. Comparable because it provides the live-casino experience layer that Slot777 resells and is itself moving into slots via acquisitions (NetEnt, Red Tiger), blurring the operator/provider line.
  • Bet365: Global online gambling incumbent operating sportsbook, casino, and poker across dozens of regulated markets. Comparable as a benchmark for the multi-vertical online gambling business model Slot777 is pursuing, though with a regulated-market profile and vastly larger scale.

Direct peers

  • IDN Poker: Indonesia-headquartered online poker network that also distributes adjacent casino and slot content to Indonesian-facing agents. Comparable because it shares the same Indonesian player base, multi-provider aggregation model, and reliance on local payment rails.

Emerging players

  • Pragmatic Play: Major iGaming content provider whose slot and live-casino titles (e.g. Gates of Olympus 1000) are the anchor content on Slot777. Comparable as both an upstream supplier and a brand that increasingly operates its own branded aggregation and operator services into Indonesia-adjacent markets.
  • PG Soft: Mobile-first slot game provider (Mahjong Ways, Lucky Neko) heavily distributed on Indonesian gambling platforms. Comparable because it competes for the same Indonesian casual-slot player attention and increasingly bundles distribution/operator services.
  • Habanero: Slot and table-game provider distributed across Asian-facing aggregators including Slot777. Comparable because it both supplies and competes for shelf-space inside Indonesian multi-provider gambling platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks7 records

Key highlights6 records

Customer concentration

CardioCell social profiles

Digital presence

CardioCell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CardioCell leadership team

Management profile

Number of profiles

CardioCell funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CardioCell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioCell

What does CardioCell do?

CardioCell operates an Indonesia-targeted online gambling platform (DBA: Slot777) that aggregates more than 30 third-party game providers into a single self-serve web account. Offerings span video slots, live casino, sports betting, togel lottery, crash games, arcade, poker, e-sports, and sabung ayam (cockfighting). The platform monetizes via house edge / transaction fees on wagers and differentiates on a 1000 IDR (~USD 0.06) minimum deposit with full Indonesian e-wallet and QRIS payment integration.

Is CardioCell a public or private company?

CardioCell is a private company. It is classified as unknown and is currently operating.

When was CardioCell founded?

CardioCell was founded in 2013. It employs 1 to 10 people.

Where is CardioCell based?

CardioCell is headquartered in San Diego, United States, in the North America region.

How does CardioCell make money?

Four revenue lines are on record. House Edge from Slot Games are the primary driver. The others are casino and Live Dealer Games, sports Betting and togel/Lottery.

Who are CardioCell's main competitors?

Broad incumbents on record are Sbobet, Maxbet, 1xBet, Playtech, Evolution Gaming and Bet365. IDN Poker is listed as a direct peer. Emerging players are Pragmatic Play, PG Soft and Habanero.

Does CardioCell have an API?

No public API is recorded for CardioCell.

What industry is CardioCell in?

CardioCell's product category is Online gambling platform. Its primary akta.pro industry code is MPAEABAA, Real-Money Online Casino Operators (RNG Slots & Table Games), with a secondary code of MPAEAKAA, iGaming Platform Providers (Turnkey/Casino & Sportsbook Platforms).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePositive Results From Study Sponsored by CardioCell Post in the American Heart Association's Journal "Circulation Research"A Phase IIa clinical trial sponsored by CardioCell LLC demonstrated that intravenous administration of ischemia-tolerant mesenchymal stem cells (itMSCs) is safe and improves outcomes for patients with non-ischemic cardiomyopathy, with statistically significant improvements in 6-minute walk test and quality-of-life scores. The study results were published in the American Heart Association's peer-reviewed journal 'Circulation Research.' Based on these promising findings, CardioCell is currently developing larger studies for heart failure indications including both non-ischemic and ischemic cardiomyopathy.BioinformantResults From Pre-Clinical Study Using CardioCell’s Stem Cells for Acute Myocardial Infarction (AMI)CardioCell LLC announced pre-clinical study results presented at the European Society of Cardiology Congress, indicating that its ischemia-tolerant mesenchymal stem cells (itMSCs) improve cardiac function in mice following acute myocardial infarction. The study demonstrated that intravenous administration of these cells prevents adverse left ventricular remodeling and reduces inflammatory responses by suppressing natural killer cells. These findings suggest a new therapeutic mechanism for treating heart attacks distinct from traditional direct tissue regeneration approaches.PR NewswireEuropean Society of Cardiology (ESC) Congress Presentation Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells for Acute Myocardial Infarction (AMI)CardioCell LLC presented pre-clinical data at the European Society of Cardiology Congress showing that intravenous administration of ischemia-tolerant mesenchymal stem cells (itMSCs) improved cardiac function in mice following acute myocardial infarction. The study demonstrated that itMSCs prevented adverse left ventricular remodeling and reduced inflammatory natural killer cell counts through systemic anti-inflammatory effects. CardioCell holds an exclusive worldwide license for these itMSC technologies from its parent company, Stemedica Cell Technologies Inc.PR NewswireEuropean Society of Cardiology (ESC) Selects CardioCell's Heart Failure (HF) Study Results for ESC Congress 2016 Late-Breaking Science SessionThe European Society of Cardiology has selected CardioCell's Phase IIa heart failure study for a 'Hot Line' Late-Breaking Science Session at ESC Congress 2016, where Dr. Javed Butler will present results on the safety and efficacy of ischemia-tolerant allogeneic mesenchymal stem cells in patients with non-ischemic cardiomyopathy on August 28 at Fiera di Roma. CardioCell LLC, a subsidiary of Stemedica Cell Technologies, developed this therapy using stem cells grown under hypoxic conditions, which the company claims demonstrate greater homing, engraftment, and secretion of growth factors compared to cells manufactured under normal oxygen conditions. The Phase IIa study was conducted at five U.S. academic medical institutions including Emory University, Northwestern University, Stony Brook University, and the University of Pennsylvania.PR NewswireCardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart FailureCardioCell LLC has completed enrollment for its Phase IIa clinical trial evaluating the safety and preliminary efficacy of ischemia-tolerant allogeneic mesenchymal stem cells in patients with non-ischemic chronic heart failure. The study, involving 23 participants across five U.S. centers, aims to determine if the therapy improves patient outcomes before advancing to larger studies. CardioCell holds an exclusive license from its parent company, Stemedica Cell Technologies Inc., for this proprietary stem cell technology.PR NewswireCardioCell Expands Chronic Heart Failure Phase IIa Clinical Trial to MedStar Washington Hospital CenterCardioCell LLC has added MedStar Washington Hospital Center as a new site for its Phase IIa clinical trial on chronic heart failure, bringing the total number of participating research centers to five. This expansion is intended to support participant recruitment and prepare for a subsequent Phase IIb study recommended by the company's advisory board.